Conduit Pharmaceuticals Inc
CDT
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.05M
Close$
$0.05
94.1% downside
Current Fair Value
94.1% downsideOvervalued by 94.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.05 Million |
|---|---|
| Enterprise Value | $1.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1177.9 |
| Beta | 1.57 |
| Outstanding Shares | 38,814 |
Return
| Return on Equity | 28.12% |
|---|---|
| Return on Assets | 10.62% |
| Return on Invested Capital | 11.58% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.14 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | 3.36 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 1.25 |
| Debt to Equity | 1.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
June 4, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $571▼ 98.62% |
| Investors Holding | 2▼ 7.00% |
ESG Score
No data